| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.02B | 59.05B | 72.40B | 82.99B | 90.06B |
| Gross Profit | 8.46B | 8.60B | 9.02B | 13.15B | 16.76B |
| EBITDA | 7.78B | 3.96B | 2.79B | 6.70B | 10.02B |
| Net Income | 1.22B | 1.06B | -6.90B | 1.98B | 4.69B |
Balance Sheet | |||||
| Total Assets | 441.92B | 409.26B | 407.12B | 421.90B | 412.00B |
| Cash, Cash Equivalents and Short-Term Investments | 32.40B | 30.81B | 30.92B | 37.10B | 31.05B |
| Total Debt | 145.41B | 123.93B | 128.49B | 123.79B | 108.09B |
| Total Liabilities | 337.51B | 300.98B | 297.28B | 309.21B | 305.21B |
| Stockholders Equity | 38.06B | 53.58B | 39.29B | 47.45B | 49.96B |
Cash Flow | |||||
| Free Cash Flow | -6.04B | -4.33B | 2.19B | 1.04B | 3.53B |
| Operating Cash Flow | -5.66B | -3.63B | 3.09B | 1.78B | 4.44B |
| Investing Cash Flow | 9.90B | 1.01B | 1.65B | 3.86B | -11.80B |
| Financing Cash Flow | -6.64B | 2.50B | -10.91B | 352.25M | -1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$10.01B | -1.82 | -2.88% | ― | -11.68% | -3002.05% | |
46 Neutral | HK$17.97B | 12.03 | 1.53% | 2.46% | -8.18% | ― | |
41 Neutral | HK$14.98B | 33.84 | 0.46% | ― | -30.32% | ― | |
40 Underperform | HK$5.18B | -24.06 | -25.72% | ― | -54.25% | -134.22% | |
39 Underperform | HK$13.17B | 3.16 | -3.01% | ― | -19.37% | 72.77% |